Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OCUL compared with MLTX: revenue, margins and what each company keeps, and the suppliers and customers both name
OCUL
Ocular Therapeutix, Inc
Change
Mkt cap
Revenue
Revenue
MLTX
MoonLake Immunotherapeutics
Change
Mkt cap
Revenue
Revenue
vs
Compare
OCUL
Ocular Therapeutix, Inc
vs
MLTX
MoonLake Immunotherapeutics
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
OCUL, solid
MLTX, dashed
Supply-chain overlap
Revenue flow
OCUL: latest quarter is a loss; flow not drawable. MLTX: latest quarter not drawable.
Method
›
OCUL
Ocular Therapeutix, Inc
Change
6.98
▼
−4.54%
· post 6.98
Mkt cap
$1.5B
Revenue
$13M
Q2 FY26
Revenue
$52M
FY25
MLTX
MoonLake Immunotherapeutics
Change
11.78
▼
−6.28%
· post 11.78
Closed
Oct 30 '26
Mkt cap
$1.0B
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
OCUL
Ocular Therapeutix, Inc
vs
MLTX
MoonLake Immunotherapeutics
6.98
▼
−4.54%
post 6.98
Price
11.78
▼
−6.28%
post 11.78
$1.5B
Mkt cap
$1.0B
Q2 FY26
$13M
Revenue
—
FY25
$52M
Revenue
—
Change
Change
OCUL
6.98
▼
−4.54%
vs
MLTX
11.78
▼
−6.28%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OCUL
7
—
Incept
unlisted
supplier
—
Ambulatory surgery centers
unlisted
customer
—
Hospital outpatient departments
unlisted
customer
—
Physicians' offices
unlisted
customer
3 more · OCUL chain
›
Shared
0
No shared counterparties.
Only MLTX
1
—
Merck Healthcare KGaA, Darmstadt, Germany
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR